HFM
ALNY icon

Harvest Fund Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Harvest Fund Management’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3M Buy
9,981
+127
+1% +$38.3K 0.1% 120
2026
Q1 		$3.26M Sell
9,854
-465
-5% -$158K 0.14% 106
2025
Q4 		$4.1M Buy
10,319
+8,298
+411% +$3.67M 0.15% 106
2025
Q3 		$920K Buy
2,021
+896
+80% +$365K 0.04% 200
2025
Q2 		$366K Buy
+1,125
New +$311K 0.02% 275
2024
Q4 		– Sell
-162
Closed -$45K – 729
2024
Q3 		$45K Buy
+162
New +$42.2K ﹤0.01% 465
2024
Q1 		– Sell
-23
Closed -$4K – 658
2023
Q4 		$4K Hold
23
– – ﹤0.01% 579
2023
Q3 		$4K Hold
23
– – ﹤0.01% 571
2023
Q2 		$4K Sell
23
-95
-81% -$18.8K ﹤0.01% 602
2023
Q1 		$24K Sell
118
-283
-71% -$59.5K 0.01% 558
2022
Q4 		$95K Buy
+401
New +$85.5K 0.02% 342
2022
Q2 		– Sell
-342
Closed -$55K – 712
2022
Q1 		$55K Sell
342
-532
-61% -$81.1K 0.01% 414
2021
Q4 		$148K Hold
874
– – 0.03% 290
2021
Q3 		$165K Buy
874
+783
+860% +$147K 0.04% 188
2021
Q2 		$15K Hold
91
– – ﹤0.01% 668
2021
Q1 		$12K Buy
+91
New +$13.7K ﹤0.01% 735
2020
Q4 		– Sell
-928
Closed -$131K – 578
2020
Q3 		$131K Buy
928
+380
+69% +$54K 0.01% 229
2020
Q2 		$81K Sell
548
-414
-43% -$55.8K 0.01% 265
2020
Q1 		$104K Sell
962
-46
-5% -$5.31K 0.01% 197
2019
Q4 		$119K Buy
+1,008
New +$100K 0.01% 160

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harvest Fund Management's ALNY Position: Q2 2026 in Review

Harvest Fund Management increased its Alnylam Pharmaceuticals (ALNY) stake by 1.3% in Q2 2026, buying an estimated $38.3K and bringing the position to 9,981 shares worth $3M. The position accounts for 0.1% of the portfolio, ranked #120.

Harvest Fund Management first reported a position in ALNY in Q4 2019 and has held it in 20 quarters since. The position peaked at $4.1M in Q4 2025. 790 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Harvest Fund Management held 9,981 shares of Alnylam Pharmaceuticals worth $3M as of Q2 2026.
  • Harvest Fund Management bought 127 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $38.3K.
  • Alnylam Pharmaceuticals made up 0.1% of Harvest Fund Management's portfolio in Q2 2026, its #120 holding.
  • Harvest Fund Management first reported a position in Alnylam Pharmaceuticals in Q4 2019 and has held it in 20 quarters since.
  • Harvest Fund Management's Alnylam Pharmaceuticals position peaked at $4.1M in Q4 2025.
  • 790 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Harvest Fund Management's 13F filing for Q2 2026, filed 20 Aug 2026.